missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ Human Parkin (aa 298-313) Synthetic Peptide

Synthetic Peptide

Brand:  Invitrogen™ PEP159

Product Code. 11504820

  • 190.00 EUR / 50µg

Please to purchase this item. Need a web account? Register with us today!

Explore more special offers
This item is not returnable. View return policy

Description

Description

Human Parkin (residues 298-313) Synthetic Peptide, PEP-159, from Invitrogen.

PEP-159 is a 15 amino acid synthetic peptide whose sequence is from human parkin. The sequence of this peptide is (amino to carboxy terminus): C- I (298)-K-E-L-H-H-F-R-I-L- G-E-E-Q-Y-N (313)This peptide may be used for neutralization and control experiments with the polyclonal antibody that reacts with this product and human parkin, catalog # PA1-751. Using a solution with equal weights per unit volume of peptide and corresponding antibody will yield a solution with a large molar excess of peptide that is able to competitively bind the antibody.Reconstitute with 0.1 ml of distilled water.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

5071
purified
Human Parkin (aa 298-313)
-20°C. Avoid freeze-thaw cycles.
Lyophilized
Control
Yes
Peptide
RUO - research use only
Human
O60260
0.5 mg/mL
Synthetic Peptide
peptide with no preservative
PRKN
No preservative
50 μg
C- I(298)-K-E-L-H-H-F-R-I-L- G-E-E-Q-Y-N(313)
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Special Offers

Special Offers

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.